{"id":83670,"date":"2017-08-24T10:31:50","date_gmt":"2017-08-24T10:31:50","guid":{"rendered":"http:\/\/mostafa.openonline.co.uk\/?guid=7732c337e76a7a65183deb2202216844"},"modified":"2017-08-24T10:31:50","modified_gmt":"2017-08-24T10:31:50","slug":"press-release-batches-of-novopen-echo-novopen-5-recalled-due-to-risk-of-fault","status":"publish","type":"post","link":"https:\/\/mostafa.openonline.co.uk\/?p=83670","title":{"rendered":"Press release: Batches of NovoPen Echo &amp; NovoPen 5 recalled due to risk of fault"},"content":{"rendered":"<div class=\"govspeak\">\n<p>People with diabetes who use NovoPen\u00ae Echo\u00ae and NovoPen\u00ae 5 should check to see if their devices are included in the <a rel=\"external\" href=\"https:\/\/mhra.filecamp.com\/public\/file\/2na9-b1mut4ee\">company-led recall by Novo Nordisk<\/a>.<\/p>\n<p>The insulin cartridge holder in certain batches may crack or break resulting in an under-delivery of insulin which can lead to high blood glucose (hyperglycaemia) and can have serious health implications.<\/p>\n<p>Novo Nordisk has detected the insulin cartridge holder used in a number of NovoPen\u00ae Echo\u00ae and NovoPen\u00ae 5 batches can be structurally compromised if exposed to certain chemicals, for example household cleaning agents.<\/p>\n<p>People using devices from the affected batches should contact Novo Nordisk to replace the cartridge holder.<\/p>\n<p>John Wilkinson, <abbr title=\"Medicines &amp; Healthcare products Regulatory Agency\">MHRA<\/abbr>\u2019s Director of Medical Devices said:<\/p>\n<blockquote>\n<p>This is a company-led recall and we are supportive of the proactive approach being taken by Novo Nordisk.<\/p>\n<p>It is important patients do not stop treatment without contacting their diabetes management team. We are asking people using a NovoPen\u00ae Echo\u00ae and\/or NovoPen\u00ae 5 from one of the affected batches to contact Novo Nordisk to replace the cartridge holder as some could be damaged or subject to damage in the future.<\/p>\n<p class=\"last-child\">We continue to encourage people to report any issues involving medical devices to the <abbr title=\"Medicines &amp; Healthcare products Regulatory Agency\">MHRA<\/abbr> via our Yellow Card Scheme.<\/p>\n<\/blockquote>\n<p>Dan Howarth, Head of Care at Diabetes UK said:<\/p>\n<blockquote>\n<p>Ensuring the correct level on insulin is vitally important in the management of diabetes; so it\u2019s important that anyone affected by this recall contact Novo Nordisk to arrange for a replacement cartridge holder.<\/p>\n<p class=\"last-child\">If they have any concerns about their level of insulin they should consult with their diabetes care team.<\/p>\n<\/blockquote>\n<div class=\"contact postal-address\" id=\"contact_2345\">\n<div class=\"content\">\n<h3>Media enquiries<\/h3>\n<div class=\"vcard contact-inner\">\n<p class=\"adr\">\n<span class=\"fn\">News centre<\/span><br \/>\n<span class=\"street-address\"><abbr title=\"Medicines &amp; Healthcare products Regulatory Agency\">MHRA<\/abbr><br \/>\n<br \/>\n151 Buckingham Palace Road<br \/>\n<br \/>\nVictoria<\/span><br \/>\n<span class=\"locality\">London<\/span><br \/>\n<span class=\"postal-code\">SW1W 9SZ<\/span>\n<\/p>\n<div class=\"email-url-number\">\n<p class=\"email\">\n              <span class=\"type\">Email<\/span><br \/>\n              <a class=\"email\" href=\"mailto:newscentre@mhra.gov.uk\">newscentre@mhra.gov.uk<\/a>\n            <\/p>\n<p class=\"tel\">\n              <span class=\"type\">During office hours:<\/span><br \/>\n              020 3080 7651 (08:30 &#8211; 17:00)\n            <\/p>\n<p class=\"tel\">\n              <span class=\"type\">Out of office hours:<\/span><br \/>\n              07770 446 189 (17:00 &#8211; 08:30)\n            <\/p>\n<\/p><\/div>\n<p class=\"comments\">Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at <a href=\"https:\/\/www.twitter.com\/mhrapress\">https:\/\/www.twitter.com\/mhrapress<\/a><\/p>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Certain batches of the NovoPen\u00ae Echo\u00ae and NovoPen\u00ae 5 are being recalled by the manufacturer Novo Nordisk.<\/p>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"_links":{"self":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/83670"}],"collection":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=83670"}],"version-history":[{"count":0,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=\/wp\/v2\/posts\/83670\/revisions"}],"wp:attachment":[{"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=83670"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=83670"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mostafa.openonline.co.uk\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=83670"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}